Company Profiles

driven by the PitchBook Platform

Chroma Therapeutics

Description

Developer of biotechnology products for cancer treatment. The company engages in discovery and development of small molecule drugs based upon chromatin biology and cell accumulation approaches which aims at the treatment of high-prevalence cancers and inflammatory disorders.

2000

Founded

PRIVATE

Status

51-200

Employees

Senior Debt

Latest Deal Type

$15M

Latest Deal Amount

$113M

Total Amount Raised

Description

Developer of biotechnology products for cancer treatment. The company engages in discovery and development of small molecule drugs based upon chromatin biology and cell accumulation approaches which aims at the treatment of high-prevalence cancers and inflammatory disorders.

Website:

www.chromatherapeutics.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

93 Innovation Drive Milton Park, Abingdon Milton OX14 4RYEngland +44 (0)12 3582 9120
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Chroma Therapeutics's full profile, request a free trial.

    Chroma Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Chroma Therapeutics Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Chroma Therapeutics Investors (11)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Abingworth ManagementVenture CapitalMinority000 0000000 0000
    Cambridge EnterpriseVenture CapitalMinority000 0000000 0000
    Cancer Research TechnologyVenture CapitalMinority000 0000000 0000
    EW Healthcare PartnersGrowth/ExpansionMinority000 0000000 0000
    Gilde Healthcare PartnersVenture CapitalMinority000 0000000 0000
    Abingworth Management Venture Capital
    Cambridge Enterprise Venture Capital
    Cancer Research Technology Venture Capital
    EW Healthcare Partners Growth/Expansion
    Gilde Healthcare Partners Venture Capital

    Chroma Therapeutics Executive Team (4)

    NameTitleBoard
    Seat
    Contact
    Info
    Richard BungayBoard Member, Chief Executive Officer and Secretary
    Alan DavidsonDirector, Pre-Clinical Development (consultant)
    David Moffat Ph.DHead of Chemistry
    Martin ToalChief Medical Officer
    Richard Bungay Board Member, Chief Executive Officer and Secretary
    Alan Davidson Director, Pre-Clinical Development (consultant)
    David Moffat Ph.D Head of Chemistry
    Martin Toal Chief Medical Officer

    Chroma Therapeutics Board Members (5)

    NameRepresentingRoleSinceContact
    Info
    Leo YipSelfBoard Member000 0000
    Richard BungayChroma TherapeuticsBoard Member, Chief Executive Officer and Secretary000 0000
    Steven Powell Ph.DBoard Member000 0000
    Timothy HainesAbingworth ManagementManaging Partner000 0000
    Toby Sykes Ph.DEW Healthcare PartnersManaging Director000 0000
    Leo Yip Board Member Self
    Richard Bungay Board Member, Chief Executive Officer and Secretary Chroma Therapeutics
    Steven Powell Ph.D Board Member
    Timothy Haines Managing Partner Abingworth Management
    Toby Sykes Ph.D Managing Director EW Healthcare Partners
    Request full access to PitchBook